Why I Don’t Believe Larry Ellison’s Moderna Stock Hype
Moderna (MRNA) stock surged 7% this week following Oracle (ORCL) CEO Larry Ellison’s claims that artificial intelligence (AI) could help develop messenger RNA-based (mRNA) vaccines to cure cancer. We’ve all heard such blusterous aspirational hype before, to be sure. Yet, his comments represent a rare upward price catalyst for Moderna, a pharma giant currently under the kosh for vaccine pricing, patent violations, regulatory failures, and transparency issues in recent months. However, despite the